We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Elevance Health's Value-Based Care Strategy Fuel Long-Term Growth?
Read MoreHide Full Article
Key Takeaways
Elevance Health is growing its value-based care portfolio in behavioral health and oncology.
The Carelon business integrates pharmacy, behavioral health and complex care management.
Medicare Advantage memberships rose 11% and total revenues climbed 13.4% Y/Y.
Elevance Health, Inc. (ELV - Free Report) , one of the largest health insurers in the United States, has been actively expanding its focus toward value-based care. This move indicates that the company visualizes the future of healthcare driven by patient outcomes.
Unlike traditional models that focus on the quantity of care provided, value-based care emphasizes coordinated treatment, preventive strategies and cost efficiency. ELV is expanding its value-based care portfolio, especially in behavioral health and oncology. Through its Carelon business, the company integrates pharmacy, behavioral health and complex care management by creating a comprehensive approach to address the needs of its members.
Elevance Health’s care delivery services primarily focus on serving chronic and complex populations by offering tailored care in the home and virtually. The company acquired CareBridge in 2024, which provides virtual care to Medicaid and Medicare patients and helps in plans in managing home and community-based services. Through this strategy, it aims to improve its visibility and consistency in the long run.
These strategies can help ELV gain more membership and retain consumers. In the last reported quarter, the company’s Medicare Advantage memberships improved 11% year over year, while individual membership grew 5.2%. In the same quarter, its total revenues rose 13.4% year over year.
If ELV can efficiently manage provider networks and scale its operations while managing upfront costs, its focus on value-based care can turn into a powerful engine for long-term growth.
How Are Competitors Faring?
Some of ELV’s competitors in the value-based care space are UnitedHealth Group Incorporated (UNH - Free Report) and Humana Inc. (HUM - Free Report) .
With the help of its Optum division, UnitedHealth Group aims to reduce hospital admissions, enhance chronic condition management and improve patient satisfaction, which plays a crucial role in shaping outcomes and managing costs. In the first half of 2025, UnitedHealth Group reported 5.8% year-over-year growth in revenues in its Optum business.
Humana’s CenterWell business offers services like pharmacy, primary care and home health solutions, which are designed to improve the overall healthcare experience. Humana’s revenues from the CenterWell unit rose 8.9% year over year in the first half of 2025.
Shares of ELV have lost 14.1% in the year-to-date period compared with the industry’s decline of 0.7%.
Image Source: Zacks Investment Research
From a valuation standpoint, Elevance Health trades at a forward price-to-earnings ratio of 9.62, down from the industry average of 15.16. ELV has a Value Score of A at present.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Elevance Health’s 2025 earnings is pegged at $30.15 per share, implying an 8.8% decline from the year-ago period.
Image Source: Zacks Investment Research
The stock currently carries a Zacks Rank #5 (Strong Sell).
Image: Bigstock
Can Elevance Health's Value-Based Care Strategy Fuel Long-Term Growth?
Key Takeaways
Elevance Health, Inc. (ELV - Free Report) , one of the largest health insurers in the United States, has been actively expanding its focus toward value-based care. This move indicates that the company visualizes the future of healthcare driven by patient outcomes.
Unlike traditional models that focus on the quantity of care provided, value-based care emphasizes coordinated treatment, preventive strategies and cost efficiency. ELV is expanding its value-based care portfolio, especially in behavioral health and oncology. Through its Carelon business, the company integrates pharmacy, behavioral health and complex care management by creating a comprehensive approach to address the needs of its members.
Elevance Health’s care delivery services primarily focus on serving chronic and complex populations by offering tailored care in the home and virtually. The company acquired CareBridge in 2024, which provides virtual care to Medicaid and Medicare patients and helps in plans in managing home and community-based services. Through this strategy, it aims to improve its visibility and consistency in the long run.
These strategies can help ELV gain more membership and retain consumers. In the last reported quarter, the company’s Medicare Advantage memberships improved 11% year over year, while individual membership grew 5.2%. In the same quarter, its total revenues rose 13.4% year over year.
If ELV can efficiently manage provider networks and scale its operations while managing upfront costs, its focus on value-based care can turn into a powerful engine for long-term growth.
How Are Competitors Faring?
Some of ELV’s competitors in the value-based care space are UnitedHealth Group Incorporated (UNH - Free Report) and Humana Inc. (HUM - Free Report) .
With the help of its Optum division, UnitedHealth Group aims to reduce hospital admissions, enhance chronic condition management and improve patient satisfaction, which plays a crucial role in shaping outcomes and managing costs. In the first half of 2025, UnitedHealth Group reported 5.8% year-over-year growth in revenues in its Optum business.
Humana’s CenterWell business offers services like pharmacy, primary care and home health solutions, which are designed to improve the overall healthcare experience. Humana’s revenues from the CenterWell unit rose 8.9% year over year in the first half of 2025.
Elevance Health’s Price Performance, Valuation & Estimates
Shares of ELV have lost 14.1% in the year-to-date period compared with the industry’s decline of 0.7%.
Image Source: Zacks Investment Research
From a valuation standpoint, Elevance Health trades at a forward price-to-earnings ratio of 9.62, down from the industry average of 15.16. ELV has a Value Score of A at present.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Elevance Health’s 2025 earnings is pegged at $30.15 per share, implying an 8.8% decline from the year-ago period.
Image Source: Zacks Investment Research
The stock currently carries a Zacks Rank #5 (Strong Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.